GAA
AZN icon

Global Assets Advisory’s AstraZeneca AZN Stock Holding History

Global Assets Advisory’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,175
Closed -$600K – 93
2024
Q1 		$600K Buy
+20,175
New +$2.67M 0.03% 307

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Global Assets Advisory's AZN Position: Q2 2024 in Review

Global Assets Advisory sold out of AstraZeneca (AZN) in Q2 2024, closing a stake of 20,175 shares — an estimated $600K sold.

Global Assets Advisory first reported a position in AZN in Q1 2024 and held it in 1 quarter. The position peaked at $600K in Q1 2024. 1,211 funds tracked by Wall St. Rank hold AZN as of Q2 2024.

  • Global Assets Advisory reported no remaining AstraZeneca position as of Q2 2024 after selling out during the quarter.
  • Global Assets Advisory sold 20,175 AstraZeneca shares in Q2 2024, an estimated $600K.
  • Global Assets Advisory first reported a position in AstraZeneca in Q1 2024 and held it in 1 quarter.
  • Global Assets Advisory's AstraZeneca position peaked at $600K in Q1 2024.
  • 1,211 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2024.

Based on Global Assets Advisory's 13F filing for Q2 2024, filed 30 Jul 2024.